HemostOD’s Post

https://buff.ly/4cXCfSY SelSym, a pioneering startup, is addressing the challenge of platelet storage limitations. Due to their short lifespan, platelets cannot be stored for future use, despite a substantial number of donations. The innovative solution being developed by SelSym involves the utilization of soft artificial platelets to effectively control bleeding. This groundbreaking approach holds promise in revolutionizing the way bleeding is managed. #MedicalInnovation #BleedingControl

Healthcare diagnostics startup Neuranics Lab has raised $700K in funding. The seed funding round led by Inflection Point Ventures (IPV). The Startup's mission is to revolutionize blood diagnostics. The company is developing a point-of-care blood analyzer capable of delivering complete blood count (CBC) results in less than 10 minutes using just a finger-prick sample. Neuranics was Founded in 2021 by Praveen kumar(Co-founder & CEO) and Ashutosh Patra (Co-founder & CTO). #fundingnews #healthtech

Theranautilus, a deep-tech firm developing nanorobotic solutions for healthcare, has raised $1.2 million in its seed round led by pi Ventures. The round also saw participation from Golden Sparrow Ventures and angel investors including Abhishek Goyal, founder and CEO of Tracxn, and Lalit Keshre CEO of Groww. The proceeds will be used to commercialize nanorobotics-based medical devices, initially targeting dental care applications. Srinivas, Theranautilus develops innovative nanorobotic solutions that address critical dental health challenges. This platform is set to transform issues like dental hypersensitivity, which affects over 2 billion people worldwide and represents a $6 billion market. It offers a long-term solution by using precision-manufactured nanorobots to targeted locations within dental tissues to deliver biocompatible materials. Theranautilus, backed by international patents and technology, aims to develop and commercialize precision theranostics-based interventions to manage cancer therapy and other diseases. Founders: Ambarish Ghosh, Debayan Dasgupta, and Peddi Shanmukh Srinivas Follow Rise & Shine for daily funding deals. Stay ahead, stay motivated with www.riseshine.in #deeptech #startup #funding

I’m thrilled to announce our investment in Proton Intelligence a company that aims to transform the management of cardio-kidney-metabolic diseases! 🩺💰 🚀 The company is pioneering the first of its kind Continuous Potassium Monitoring (CKM™) platform, focused on patients with severe kidney impairment, including CKD and ESRD, and aiming to address a critical unmet need in managing cardio-kidney-metabolic diseases. LongeVC is proud to co-invest alongside SOSV We Venture Capital, Tenmile 15th Rock, Exor Ventures and Trampoline Venture Partners in a $6.95 million seed financing round. Quick insights: ✔️ The purpose of funding is to support ongoing clinical feasibility trials and prepare for a pivotal study in 2026. ✔️ Potassium fluctuations are life-threatening, contributing to therapy interruptions and higher mortality for CKD and heart failure patients. ✔️ CKD impacts 14% of U.S. adults, accounting for >25% of Medicare spending, with ESRD patients representing 7% of annual Medicare expenditures. We are excited to partner with Proton Intelligence in their mission to bring this innovative solution to market, because it may improve healthcare outcomes and reduce costs for millions of patients globally. Kudos to Sahan Ranamukhaarachchi , CEO of Proton Intelligence, and the team! Happy Holidays! 🎄 #Healthcare #MedTech Image credit: Proton Intelligence

An interesting concept for management of cardio/renal/metabolic diseases.

Fluid Biomed Inc. secures $27M in oversubscribed Series A funding to advance its world-first bioabsorbable polymer-based stent for brain aneurysms. Co-led by Amplitude Ventures and a major undisclosed strategic partner, this investment includes new backers IAG Capital Partners, LifeArc Ventures, alongside returning investors ShangBay Capital and METIS Innovative. Founded by leading neurosurgeons Dr. John Wong and Dr. Alim Mitha, Fluid Biomed is poised to revolutionize brain aneurysm treatment with its innovative ReSolv™ stent, aiming to reduce reliance on blood thinners for patients. Stay ahead in the startup world! 🌟 Get a weekly digest of key happenings and insights delivered to your inbox every Monday morning. Don't miss out—subscribe now: https://lnkd.in/eR7sehfi 🚀 #Funding #MedTech #SeriesA #VascularHealth

We are thrilled for Rutgers research team Nervana Therapeutics to be part of the inaugural Venturium Virtual Showcase, where they will present the technology they developed at Rutgers to an audience of venture capital investors, venture studios, accelerators, incubators, industry partners, and entrepreneurs. Nervana Therapeutics' technology is a cellularized nerve regeneration graft (CNRG) that will speed patient recovery from peripheral nerve injury, improve recovery of sensation and motor function, reduce the need for extra surgeries, and decrease lifetime medical and socioeconomic costs of new and poorly-recovered injuries. Venturium 2024, co-sponsored by Rutgers Research, is a curated showcase highlighting spinouts and technologies from members of the Tech Transfer Venture Consortium (TTVC), including Rutgers and fellow co-sponsors Kentucky Commercialization Ventures, Innovate Carolina, Northeastern University Center for Research Innovation (CRI), and PCI Ventures. This event embodies a movement towards collaborative growth, technological advancement, and revolutionizing access to academic venture opportunities.   #RutgersInnovation #RutgersResearch #venturium24 #techtransfer #techinnovation #techventures #ventureforward #cofounderconnection #collaborativegrowth

ShiraTronics Secures $66M to Advance Novel Therapy for Migraine MedTech startup ShiraTronics, Inc. has secured $66 million in Series B funding round to advance implantable neuromodulation device for treatment-resistant migraine to FDA-approved pivotal clinical trials, the company announced last Wednesday. Co-founded in 2018 by Mudit K. Jain, PhD, CEO and partner at Treo Ventures, ShiraTronics leverages advanced technologies to develop an effective therapy for chronic migraines. The company’s series B round was led by a new investor Norwest Venture Partners, with notable contributions from Seroba., the Global BioAccess Fund, and OSF HealthCare, alongside other undisclosed strategic investors. The round also saw the participation of existing investors Amzak Health, U.S. Venture Partners, Aperture Venture Partners, and Treo Ventures. Read more: https://lnkd.in/gjxksabM #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #MedicalDevice #MigraineTreatment #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

We're thrilled to announce that Legal-Pythia has been named one of the top 50 startups to watch in the Glasgow City Region! 🚀 This recognition is a powerful validation of our mission to revolutionize legal operations through AI. We're honored to be included among the most promising companies in the region. Let's continue to push the boundaries of legal tech together! #LegalTech #Startup #Glasgow #Innovation #AI #LegalPythia #FinTech #ExplainableAI #Financials #FinancialServices #FraudDetection #documentautomation #ukstartup #legalindustry

Neuranics Lab, a healthcare diagnostics startup, has raised $700K in its seed round led by Inflection Point Ventures (IPV). The proceeds will be used for technology development and clinical validation, enabling the company to progress toward commercial production post-CDSCO licensing. Neuranics is developing a point-of-care blood analyzer capable of delivering complete blood count (CBC) results in less than 10 minutes using just a finger-prick sample. The device, designed for primary and emergency settings, offers low maintenance and high efficiency, making it a game-changer for the healthcare industry. At the same time, life-saving treatments for critical conditions like sepsis, severe anemia, and thrombocytopenia, especially in dengue patients, can be initiated promptly, ensuring timely and effective care. Founders: Praveen Kumar Bhagat and Ashutosh Patra Follow Rise & Shine for daily funding deals. Stay ahead, stay motivated with www.riseshine.in #healthcare #startup #funding